V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001221 | 230000821 | 1.67 | 60.65 | Palliative (P) | 2017-12-08 | 2017-12-16 | CISPLATIN + GEMCITABINE | N | N | 230003903 | DOCETAXEL |
| 230001222 | 230000822 | 1.6 | 55.5 | Adjuvant (A) | 2017-08-07 | 2017-08-20 | Capecitabine + Oxaliplatin 14day | 02 | N | 230003913 | CAPECITABINE + OXALIPLATIN |
| 230001223 | 230000823 | 1.55 | 84.7 | Palliative (P) | 2016-09-17 | 2016-10-16 | Rituximab | N | N | 230003913 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230001224 | 230000825 | 1.68 | null | Not known (9) | 2016-04-24 | 2016-05-09 | DA-EPOCH-R | 02 | N | 230004025 | ETOPOSIDE |
| 230001225 | 230000825 | 1.85 | 89 | Palliative (P) | 2013-11-20 | 2013-11-21 | Capecitabine + Oxaliplatin 21day | N | N | 230004025 | CAPECITABINE + OXALIPLATIN |
| 230001226 | 230000825 | 1.53 | 81.8 | Palliative (P) | 2016-06-28 | 2016-09-21 | Sorafenib | 02 | N | 230004025 | CETUXIMAB |
| 230001227 | 230000826 | 1.68 | 130.7 | Adjuvant (A) | 2016-05-24 | 2016-07-22 | PACLITAXEL | 2 | N | 230004131 | TRASTUZUMAB |
| 230001228 | 230000827 | 1.73 | 97.499 | Adjuvant (A) | 2018-02-17 | 2018-03-03 | R GCVP | 2 | N | 230004137 | ABIRATERONE |
| 230001229 | 230000829 | null | 59 | Palliative (P) | 2014-11-07 | 2014-11-07 | AFLIBERCEPT + FU + IRINOTECAN | 99 | N | 230004137 | TRIAL |
| 230001230 | 230000830 | 1.74 | 67.2 | Palliative (P) | 2017-10-28 | 2017-11-29 | GEFITINIB | N | N | 230004260 | CETUXIMAB + RT |
| 230001231 | 230000831 | 1.79 | 95 | Adjuvant (A) | 2014-11-11 | 2015-02-01 | Cisplatin + Vinorelbine (PO) | N | N | 230004285 | VANDETANIB |
| 230001232 | 230000832 | null | 101 | Palliative (P) | 2015-06-26 | 2015-07-02 | CYTARABINE | 2 | N | 230004340 | CAPECITABINE + OXALIPLATIN |
| 230001233 | 230000832 | 1.54 | 53 | Adjuvant (A) | 2018-12-15 | 2018-12-15 | Trastuzumab Subcutaneous | 02 | N | 230004340 | EC |
| 230001234 | 230000832 | null | 85.9 | Palliative (P) | 2016-01-27 | 2016-01-27 | Irinotecan + Modified De Gramont | N | N | 230004340 | PACLITAXEL |
| 230001235 | 230001363 | null | 80.2 | null | 2014-10-04 | 2014-10-14 | LENVATINIB | 02 | null | 230004614 | NOT MATCHED |
| 230001236 | 230000834 | 1.5 | 51.8 | Curative (C) | 2015-12-13 | 2016-05-01 | Irinotecan + Modified De Gramont | 02 | N | 230004622 | TRIAL |
| 230001237 | 230000835 | 1.6 | 62.7 | Palliative (P) | 2018-12-14 | 2018-12-15 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 230004650 | CABAZITAXEL |
| 230001238 | 230000837 | 1.79 | null | Palliative (P) | 2017-03-07 | 2017-03-07 | Trifluridine + Tipiracil | N | N | 230004668 | FLUOROURACIL |
| 230001239 | 230000838 | 1.6 | null | Palliative (P) | 2015-11-16 | 2015-11-17 | Trastuzumab 21 day maintenance | 02 | N | 230004751 | TRASTUZUMAB |
| 230001240 | 230000839 | 1.7 | 98.9 | Palliative (P) | 2014-10-20 | 2014-10-20 | IVA | N | N | 230004751 | IRINOTECAN + MDG |
| 230001241 | 230000840 | 1.55 | null | Not known (9) | null | 2017-12-09 | Capecitabine | 2 | null | 230004832 | GEMCARBO |
| 230001242 | 230000840 | 1.71 | 52.5 | Curative (C) | null | 2016-05-06 | Trastuzumab Subcutaneous | N | null | 230004832 | PACLITAXEL |
| 230001243 | 230000841 | null | 86.3 | Palliative (P) | 2016-11-07 | 2017-01-31 | Fluorouricil + Folonic Acid (MdG) | N | N | 230004911 | SORAFENIB |
| 230001244 | 230000842 | 1.58 | 74.3 | Adjuvant (A) | null | 2018-10-24 | Trastuzumab 21 day maintenance | N | N | 230004936 | IVA |
| 230001245 | 230000843 | null | 60 | Neo-adjuvant (N) | 2014-02-09 | 2014-02-17 | Capecitabine + Oxaliplatin 21day | N | null | 230005053 | CAPECITABINE + OXALIPLATIN |
| 230001246 | 230001368 | 1.73 | 59.4 | Not known (9) | 2015-08-22 | 2015-08-22 | Docetaxel 100mg/m2 (21 day) | 02 | null | 230005102 | CAPECITABINE + OXALIPLATIN |
| 230001247 | 230000844 | 1.6 | 152 | Not known (9) | 2015-08-20 | 2015-08-20 | Irinotecan + Modified De Gramont | 01 | N | 230005102 | RITUXIMAB |
| 230001248 | 230000844 | -1 | null | Curative (C) | 2015-09-10 | 2015-11-17 | Rituximab | N | N | 230005102 | FLUOROURACIL |
| 230001249 | 230000846 | 1.65 | 102 | Adjuvant (A) | 2014-09-01 | 2014-09-02 | Capecitabine | N | N | 230005256 | RITUXIMAB |
| 230001250 | 230000848 | 1.49 | 130.7 | Palliative (P) | 2017-04-21 | 2017-04-26 | Capecitabine | N | N | 230005319 | R-EPOCH |
| 230001251 | 230000849 | 1.73 | 86.9 | Palliative (P) | 2016-02-02 | 2016-03-16 | Irinotecan + Modified De Gramont | N | N | 230005329 | CARBOPLATIN + ETOPOSIDE |
| 230001252 | 230000851 | null | 67.6 | Palliative (P) | null | 2018-08-07 | Oxaliplatin + Modified de Gramont | 2 | N | 230005439 | FEC + TRASTUZUMAB |
| 230001253 | 230000852 | null | 73.15 | Palliative (P) | 2018-05-21 | 2018-05-28 | Capecitabine | N | Y | 230005457 | TRIAL |
| 230001254 | 230000855 | 1.73 | 79.9 | Adjuvant (A) | 2015-04-08 | 2015-04-09 | Trastuzumab 21 day maintenance | 02 | Y | 230005457 | CARBOPLATIN + ETOPOSIDE |
| 230001255 | 230000856 | null | null | Curative (C) | 2016-08-01 | 2016-08-02 | Irinotecan + Modified De Gramont | N | null | 230005495 | OXALIPLATIN + MDG |
| 230001256 | 230000857 | 1.86 | 121.2 | Palliative (P) | 2018-11-07 | 2018-11-07 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | Y | 230005517 | ENZALUTAMIDE |
| 230001257 | 230000859 | 1.65 | 83.9 | Adjuvant (A) | 2016-08-30 | 2016-08-30 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 230005755 | CARBOPLATIN + PEMETREXED |
| 230001258 | 230001375 | 1.68 | null | Not known (9) | 2014-03-10 | 2014-03-11 | Capecitabine + Oxaliplatin 21day | N | N | 230005785 | METHOTREXATE INTRATHECAL |
| 230001259 | 230001375 | 1.63 | 75.7 | Curative (C) | 2017-05-28 | 2018-01-13 | Cetuximab 14 day | N | N | 230005785 | MPT |
| 230001260 | 230000862 | 1.76 | null | Neo-adjuvant (N) | 2018-11-26 | 2018-11-26 | DOXORUBICIN | 02 | N | 230005832 | FEC + TRASTUZUMAB |
| 230001261 | 230000863 | 1.8 | null | Adjuvant (A) | 2018-02-25 | 2018-02-25 | Oxaliplatin + Modified de Gramont | N | N | 230005840 | DOCETAXEL |
| 230001262 | 230000864 | 1.7 | 84 | Palliative (P) | null | 2017-11-01 | Cisplatin + Doxorubicin | N | null | 230005912 | CARBOPLATIN + ETOPOSIDE |
| 230001263 | 230000865 | 1.7 | 56.8 | Adjuvant (A) | 2013-07-14 | 2013-07-14 | Oxaliplatin + Modified de Gramont | 2 | N | 230006101 | TRASTUZUMAB |
| 230001264 | 230000865 | 1.57 | 53.7 | Palliative (P) | 2012-08-12 | 2012-09-15 | FLUOROURACIL + OXALIPLATIN | N | N | 230006101 | CARBOPLATIN + ETOPOSIDE |
| 230001265 | 230000865 | 1.5 | 76 | Adjuvant (A) | 2017-04-05 | 2017-04-14 | Trastuzumab 21 day maintenance | N | N | 230006101 | DOCETAXEL |
| 230001266 | 230000866 | 1.5 | 73.6 | Not known (9) | 2015-08-07 | 2015-08-21 | Irinotecan + Modified De Gramont | 02 | Y | 230006193 | BENDAMUSTINE + RITUXIMAB |
| 230001267 | 230000867 | 1.66 | 51.6 | Adjuvant (A) | 2018-02-28 | 2018-03-19 | FEC + TRASTUZUMAB | N | N | 230006366 | CAPECITABINE + OXALIPLATIN |
| 230001268 | 230000868 | 1.57 | null | Neo-adjuvant (N) | 2017-05-16 | 2017-08-21 | Capecitabine + Oxaliplatin 21day | N | N | 230006781 | OXALIPLATIN + MDG |
| 230001269 | 230000869 | 1.64 | 44 | Palliative (P) | 2018-08-26 | 2018-09-16 | CAPECITABINE + TEMOZOLOMIDE | N | N | 230006826 | CAPECITABINE + OXALIPLATIN |
| 230001270 | 230001378 | 1.66 | 84 | Palliative (P) | 2018-07-28 | 2018-07-29 | GemCarbo Days 1+8 | N | N | 230007016 | DOCETAXEL |